Phase I trial of gemcitabine and vinorelbine in patients with refractory solid tumors: efficacy with minimal toxicity in a geriatric population

被引：0
|
作者：
Radice, P [1 ]
Koletsky, A [1 ]
Greenhawt, M [1 ]
Frankel, C [1 ]
Pearce, P [1 ]
Byrne, C [1 ]
Jahanzeb, M [1 ]
机构：
[1] Interctr Ctr Canc Res Grp, Palm Beach, FL USA
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [41] A phase I trial of aerosol gemcitabine for the treatment of patients with solid tumors and lung metastases.
    Gordon, Nancy Beatriz
    Kleinerman, Eugenie
    Sheshadri, Ajay
    Blanco, David
    Yedururi, Sireesha
    Morani, Ajaykumar
    Gill, Jonathan Benjamin
    Harrison, Douglas James
    Herzog, Cynthia E.
    Livingston, J. Andrew
    Benjamin, Robert S.
    Gorlick, Richard Greg
    Mireles, Maria E.
    Kawedia, Jitesh D.
    Daw, Najat C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [42] A phase I trial of romidepsin in combination with gemcitabine in patients with pancreatic and other advanced solid tumors
    Doss, H. H.
    Jones, S. F.
    Infante, J. R.
    Spigel, D. R.
    Willcutt, N.
    Lamar, R.
    Barton, J.
    Keegan, M.
    Burris, H. A., III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors
    Wagner, LM
    Crews, KR
    Iacono, LC
    Houghton, PJ
    Fuller, CE
    McCarville, MB
    Goldsby, RE
    Albritton, K
    Stewart, CF
    Santana, VM
    CLINICAL CANCER RESEARCH, 2004, 10 (03) : 840 - 848
  • [44] A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors
    Niharika B. Mettu
    Donna Niedzwiecki
    Christel Rushing
    Andrew B. Nixon
    Jingquan Jia
    Sherri Haley
    Wanda Honeycutt
    Herbert Hurwitz
    Johanna C. Bendell
    Hope Uronis
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 1025 - 1035
  • [45] Phase I trial to evaluate safety, pharmacokinetics, and efficacy of sorafenib combined with docetaxel in patients with advanced, refractory solid tumors
    Awada, A.
    Hendlisz, A.
    Whenham, N.
    Gil, T.
    Christensen, O.
    Lathia, C.
    Bartholomeus, S.
    Delabaye, I.
    De Valeriola, D.
    Brendel, E.
    Delaunoit, T.
    Piccart, M.
    ANNALS OF ONCOLOGY, 2007, 18 : 39 - 39
  • [46] Safety, Efficacy, and Pharmacokinetics of Metatinib Tromethamine Tablet in Patients with Advanced Refractory Solid Tumors: A Phase I Clinical Trial
    Cheng, Ke
    Li, Xiao-Yu
    Zhou, Yu-Wen
    Liao, Zheng-Yin
    Qiu, Meng
    Bi, Feng
    Zheng, Li
    ONCOLOGIST, 2021, 26 (08): : 649 - +
  • [47] Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies
    Mekhail, T
    Hutson, TE
    Elson, P
    Budd, GT
    Srkalovic, G
    Olencki, T
    Peereboom, D
    Pelley, R
    Bukowski, RM
    CANCER, 2003, 97 (01) : 170 - 178
  • [48] Phase I clinical trial of temsirolimus (T) and vinorelbine (V) in advanced solid tumors
    Lee, Grace Lauren
    Ji, Lingyun
    Gitlitz, Barbara Jennifer
    Dorff, Tanya B.
    Iqbal, Syma
    El-Khoueiry, Anthony B.
    Roman, Lynda
    Edwards, Susan
    Menendez, Xiomara
    Cheng, Phillip
    Quinn, David I.
    Cole, Sarah
    Garcia, Agustin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Phase I trial of weekly gemcitabine at 3-h infusion in refractory, heavily pretreated advanced solid tumors
    Maurel, J
    Zorrilla, M
    Puertolas, T
    Antón, A
    Herrero, A
    Artal, A
    Alonso, V
    Martinez-Trufero, J
    Puertas, MD
    ANTI-CANCER DRUGS, 2001, 12 (09) : 713 - 717
  • [50] Gemcitabine and carboplatin combination in advanced solid tumors: A phase I trial.
    Tassinari, D
    Pasini, G
    Arcangeli, V
    Panzini, I
    Drudi, G
    Gianni, L
    Oliverio, G
    Sartori, S
    Fochessati, F
    ANNALS OF ONCOLOGY, 2000, 11 : 141 - 141
12345